Colinz Laboratories Ltd Stock Analysis

BSE: 531210 | NSE: | Pharmaceuticals & Drugs | Small Cap

BSE Share Price Jan 25, 13:47
32.15 -1.65 (-4.88%)

DeciZen - Make an Informed Decision on Colinz Laboratories

M-Cap below 100cr DeciZen not available

FAQ's

1. Is Colinz Laboratories Ltd a good quality company?

Data is not available for this company.

2. Is Colinz Laboratories Ltd undervalued or overvalued?

The key valuation ratios of Colinz Laboratories Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Colinz Laboratories Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Colinz Laboratories Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Colinz Laboratories:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide
Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21TTM
ROCE % 2.9%2.5%1%2.2%2.2%3%4%2.6%2.4%3.5%-
Value Creation Index -0.8-0.8-0.9-0.9-0.9-0.8-0.7-0.8-0.8-0.8-

Growth Parameters

Growth Parameters Colour Code Guide
Sales 6.67.27.47.98.18.17.97.67.56.17
YoY Gr. Rt. %-8.9%2.9%6.6%2.7%-0.6%-1.9%-4.1%-0.5%-19%-
Adj EPS 0.30.20.10.30.30.40.70.30.40.60.6
YoY Gr. Rt. %--44.1%-57.9%250%-3.6%48.2%62.5%-47.7%8.8%59.5%-
BVPS (₹) 17.417.717.917.417.718.419.119.319.320.618.8
Adj Net Profit 0.10.100.10.10.10.20.10.10.20
Cash Flow from Ops. 0.30.20.60.10.60.10.30.10.62.2-
Debt/CF from Ops. 7.9152.924.62.813.31.35.80.70.5-

CAGR

CAGR Colour Code Guide
9 Years 5 Years 3 Years 1 Years
Sales -0.9%-5.5%-8.2%-19%
Adj EPS 6.3%16.9%-3.2%59.5%
BVPS 1.93.12.66.6
Share Price 22.6% 10.6% 48.1% 204.7%

Key Financial Parameters

Performance Ratio Colour Code Guide
Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21TTM
Return on Equity % 21.10.41.61.52.23.51.81.92.93.1
Op. Profit Mgn % 7.87.64.75.85.65.14.54.645.46.6
Net Profit Mgn % 1.810.41.31.21.82.91.61.73.44
Debt to Equity 0.40.40.30.40.30.10.10.10.10.10
Working Cap Days 234222220227226226224220198195359
Cash Conv. Cycle 108111110114122136137145143135237

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 3.00%

Sales growth has been subdued in last 3 years -8.21%

Net Profit has been subdued in last 3 years -3.18%

Sales growth is not so good in last 4 quarters at 6.98%

Latest Financials - Colinz Laboratories Ltd.

Standalone Consolidated
TTM EPS (₹) 0.6 -
TTM Sales (₹ Cr.) 6.9 -
BVPS (₹.) 18.8 -
Reserves (₹ Cr.) 4 -
P/BV 1.80 -
PE 56.80 -
From the Market
52 Week Low / High (₹) 7.31 / 43.45
All Time Low / High (₹) 0.25 / 43.45
Market Cap (₹ Cr.) 15.5
Equity (₹ Cr.) 4.6
Face Value (₹) 10
Industry PE 38.1

Management X-Ray of Colinz Laboratories :

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Analyst's Notes

News

About Colinz Laboratories Ltd

Colinz Laboratories was established in 1987, the company is having modern manufacturing facility near Mumbai. The company is equipped with a full fledged in house testing / quality control laboratory.

The company houses well experienced pharmacists / technical personnel in development dept / manufacturing and caters to an ethical promotion of specialty products in India.

The company is having a well experienced marketing team of over 300 personnels and is having expertise in turn key projects (Design, erection & commissioning of pharma formulation plants) Transfer of technical know how (Pilot Batch to Commercial productions).

Business area of the company spreads to:

Pharmaceutical Formulations (of all dosages forms)

  • Tablets
  • Capsules
  • Parenterals
  • Creams/ Ointments/Lotions
  • Dry Powder
  • Liquid Orals
  • Soft Gelatine Capsules

Therapeutic Segments

  • Anti Biotics & Anti Bacterials
  • Anti Hypertensives
  • Diuretics
  • Lipid lowering Agents (Cholestrole Reducers)
  • Anti Emetics etc.

Vetinary formulations

  • Feed mix
  • Bolus
  • Vitamins & Others

Nutraceuticals

  • Spirulina
  • Co enzyme Q10 
  • Clucosamine
  • Lecithin
  • Vitamins

Herbal Preparations

  • Pain Balm (Instant relief for all types of pain)
  • Anti Cold Rub 

Ayurvedic Skin Care Creams Treatment of

  • Pimples 
  • Fairness
  • Stretch Marks 
  • Cracks

Capsules/Tablets/ Creams/ Powders

  • Anti Piles
  • Laxatives
  • Anti Diabetic
  • Anti Hypertensive
  • Antacid
  • Vigour & Vitality
  • General Debility 

Contract Manufacturing & Technical Know How Product Development

- Product Development & Clinical Research - Technical know how for formulations  - Currently Manufacturing for Europeon & Japanese companies

Sourcing API& / Intermediates Turn key products 

Read More Read Less